Sapient Capital LLC Takes Position in Cardinal Health, Inc. $CAH

Sapient Capital LLC bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 2,529 shares of the company’s stock, valued at approximately $534,000.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. University of Texas Texas AM Investment Management Co. acquired a new stake in Cardinal Health in the fourth quarter worth $26,000. Bank of Jackson Hole Trust bought a new stake in Cardinal Health in the fourth quarter valued at $27,000. Indiana Trust & Investment Management Co acquired a new position in shares of Cardinal Health during the first quarter valued at about $29,000. Palladiem LLC bought a new position in shares of Cardinal Health during the 4th quarter worth about $28,000. Finally, Elyxium Wealth LLC bought a new position in shares of Cardinal Health during the 4th quarter worth about $34,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Trading Down 1.0%

NYSE CAH opened at $233.32 on Wednesday. The business has a fifty day simple moving average of $224.29 and a 200 day simple moving average of $215.72. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $243.21. The firm has a market capitalization of $54.65 billion, a P/E ratio of 35.68, a PEG ratio of 1.15 and a beta of 0.49.

Analyst Upgrades and Downgrades

Several analysts have recently commented on CAH shares. Wells Fargo & Company reduced their target price on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. TD Cowen increased their price target on Cardinal Health from $255.00 to $275.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 4th. JPMorgan Chase & Co. reduced their price objective on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research note on Monday, May 4th. Finally, Mizuho boosted their price objective on Cardinal Health from $235.00 to $240.00 and gave the company an “outperform” rating in a report on Thursday, July 23rd. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average price target of $251.73.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.